Conclusions and Future Directions

↳ This is a section part of Moment: Metabolic Therapy in Heart Failure

Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Preview

Summary

Conclusions

Increased understanding of the role of systemic and cardiac metabolism impairments in heart failure not only generates new pathophysiological concepts, but also stimulates the search for new therapies for patients with heart failure. Trimetazidine effectively regulates cardiac energy metabolism by reducing fatty acid oxidation and increasing glucose oxidation and its potential should be considered for add-on therapy with conventional treatment of heart failure.

Loading Simple Education